申请人:MaveriX Oncology, Inc.
公开号:US20210380626A1
公开(公告)日:2021-12-09
Disclosed are compounds having formula (I):
or a pharmaceutically acceptable salt, ester, amide, solvate, or stereoisomer thereof, wherein L, Y
1
, Y
2
, Y
3
, Y
4
, Y
5
, Z
1
, Z
2
, Z
3
, Z
4
, Z
5
, Z
6
, and Effector are each as defined in the specification; compositions thereof; uses thereof; and methods of use thereof.